Related Experiment Video
Updated: May 10, 2026

08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Cardiac transplantation and mechanical support for functional single ventricle
James K Kirklin1, F Bennett Pearce, Robert J Dabal
1Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
World Journal for Pediatric & Congenital Heart Surgery
|June 28, 2013
Summary
Cardiac transplantation is a vital therapy for congenital heart disease, especially failing single ventricle. Advances in mechanical circulatory support and surgical techniques are improving outcomes for these complex pediatric cardiac patients.
Area of Science:
- Cardiology
- Pediatric Cardiac Surgery
- Congenital Heart Disease
Background:
- Cardiac transplantation is a critical treatment for anatomically uncorrectable congenital heart disease, particularly failing single ventricle.
- The use of this scarce resource for complex cardiac malformations with physiologic and circulatory failure presents challenges.
- While primary cardiac transplantation for hypoplastic-left heart syndrome is uncommon, failing single ventricle patients in the Fontan pathway are increasingly considered.
Purpose of the Study:
- To review the role and outcomes of cardiac transplantation in patients with failing single ventricle.
- To discuss the evolution of surgical techniques and the impact of mechanical circulatory support in this population.
Main Methods:
- Review of historical and current literature on cardiac transplantation for single ventricle physiology.
- Analysis of outcomes data for transplantation in Fontan pathway patients.
- Discussion of advancements in mechanical circulatory support devices.
Main Results:
- Outcomes for cardiac transplantation in failing single ventricle patients have progressively improved.
- Transplantation outcomes in this complex group now approach those seen in other conditions.
- Mechanical circulatory support has successfully bridged infants and children to transplantation.
Conclusions:
- Cardiac transplantation is an increasingly viable option for failing single ventricle, especially in the Fontan pathway.
- Mechanical circulatory support offers promising new avenues for managing single ventricle patients awaiting transplant.
- Continued advancements in surgical and support technologies are crucial for improving long-term outcomes.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
